Colorectal cancer — which includes cancer of the colon and of the rectum — is considered early onset when diagnosed in people under the age of 50. While the majority of diagnoses are still among ...
Many people associate colon cancer with old age, but that's not the case anymore, as the number of young people being diagnosed is on the rise. According to the American Cancer Society, an estimated ...
Treatment with a GLP-1 receptor agonist (RA) may offer a survival advantage in patients with colon cancer and obesity. In a real-world analysis of nearly 7000 patients with colon cancer, those taking ...
New research links ultra-processed food with a higher colon cancer risk. The risk jumped 1.5 times in people with diets heavy in ultra-processed foods. Here’s what you need to know to help prevent ...
Sarah Basore, an Overland Park resident who is living with Stage 4 colon cancer, began clinical trials in August, which require weekly drives to Nashville. The current regime has stabilized her ...
After an increase in colorectal cancer among patients younger than 50, U.S. guidelines started recommending that screening begin at age 45 for average-risk adults. This study showed that ...
Kentucky has one of the highest rates of colorectal cancer in the US, but early detection leads to a 91% five-year survival rate. Colorectal cancer is projected to become the leading cancer killer for ...
Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...
Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...
Forbes contributors publish independent expert analyses and insights. A physician who writes about challenges with navigating healthcare. And while colonoscopy remains the gold standard for prevention ...
Scientists have engineered Salmonella bacteria to self-destruct inside tumors, releasing signals that spark powerful immune hubs and shrink colon cancer in mice, opening the door to “living medicines” ...